![Chemical structure of (1r,4r)-4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol, CAS 18683-91-5](https://api.angenesci.com/structure/2059/18683-91-5.png)
无数据
无数据
无数据
| CAS Number | 18683-91-5 |
| Catalog Number | AG003UXG(AGN-PC-0O5LAC) |
| Chemical Name | (1r,4r)-4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol |
| EC Number | 242-500-3 |
| IUPAC Name | 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol |
| InChI | InChI=1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2 |
| InChI Key | JBDGDEWWOUBZPM-UHFFFAOYSA-N |
| MDL Number | MFCD00242702 |
| Molecular Formula | C13H18Br2N2O |
| Molecular Weight | 378.1028 |
| SMILES | O[C@H]1CC[C@H](NCC2=CC(Br)=CC(Br)=C2N)CC1 |
| UNII | 200168S0CL |
| Synonyms | 4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol,
Abrohexal,
AM, Bisolvon,
Ambril,
Ambro Puren,
Ambro-Puren,
Ambrobeta,
Ambrofur,
Ambrohexal,
Ambrolös,
Ambrolitic,
AMBROPP,
AmbroPuren,
Ambroten,
Ambroxin,
Ambroxocompren,
Ambroxol,
Bisolvon AM,
Bromhexine Metabolite VIII,
Bronchopront,
Bronchowern,
Broxol,
Contac Husten Trunk,
Contac Husten-Trunk,
Contac HustenTrunk,
Dinobroxol,
Duramucal,
Ebromin,
Expeflen,
Expit,
Farmabroxol,
Flavamed,
Frenopect,
Gelopol,
Hustenlöser, Pect,
Hustenlöser, Therapin,
Larylin Husten Löser,
Larylin Husten-Löser,
Larylin HustenLöser,
Lasolvan,
Metabolite VIII, Bromhexine,
Mibrox,
Motosol,
Muco Fips,
Muco-Fips,
MucoFips,
Mucosolvan,
Mucotablin,
NA 872,
NA-872,
NA872,
Pädiamuc,
Pect Hustenlöser,
Pulmonal S,
Pulmonal, Ringelheimer,
Ringelheimer Pulmonal,
Sekretovit,
stas Hustenlöser,
stas-Hustenlöser,
stasHustenlöser,
Surbronc,
Therapin Hustenlöser,
ambroxol,
18683-91-5,
107814-37-9,
Ambroxolum,
Ambroxol Base,
NA-872,
Bisolvon metabolite VIII,
4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol,
36557-04-7,
Bromhexine-metabolite VIII,
4-((2-amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol,
Ambroxol [INN:BAN],
Ambroxolum [INN-Latin],
rac-cis-Ambroxol,
Bromhexine Metabolite VIII,
cis-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol,
trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol,
C13H18Br2N2O,
UNII-200168S0CL,
EINECS 242-500-3,
Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-, trans-,
trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol,
trans-4-((2-Amino-3,5-dibromobenzyl)amine)cyclohexanol,
Cyclohexanol, 4-((2-amino-3,5-dibromobenzyl)amino)- (E)-,
N-(2-Amino-3,4-dibromocyclohexyl)-trans-4-aminocyclohexanol,
N-(trans-4-Hydroxycyclohexyl)-(2-amino-3,5-dibromobenzyl)-amine,
N-(trans-p-Hydroxycyclohexyl)-(2-amino-3,5-dibromobenzyl)amine,
JBDGDEWWOUBZPM-UHFFFAOYSA-N,
200168S0CL,
trans-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol,
N-(2-Amino-3,4-dibromociclohexil)-trans-4-aminociclohexanol,
N-(trans-4-Hidroxiciclohexil)-(2-amino-3,5-dibromobencil)amina,
trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol [Spanish],
Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans-,
N-(2-Amino-3,4-dibromociclohexil)-trans-4-aminociclohexanol [Spanish],
N-(trans-4-Hidroxiciclohexil)-(2-amino-3,5-dibromobencil)amina [Spanish],
15942-05-9,
4-[(2-amino-3,5-dibromo-phenyl)methylamino]cyclohexanol,
Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-,
Ambroxol EP Impurity D,
Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-, cis-,
Ambroxol Hydrochloride Impurity D,
MFCD00078932,
NCGC00016781-04,
CAS-23828-92-4,
Amboxol,
SR-05000001463,
Ambroxol (INN),
Tabcin (TN),
Spectrum_001346,
AC1L1CZO,
Prestwick0_000366,
Prestwick1_000366,
Prestwick2_000366,
Prestwick3_000366,
Spectrum2_001518,
Spectrum3_000955,
Spectrum4_001068,
Spectrum5_001021,
EC 242-500-3,
AC1Q25NE,
Oprea1_766685,
SCHEMBL18702,
BSPBio_000491,
KBioGR_001396,
KBioSS_001826,
MLS001306470,
DivK1c_000027,
SCHEMBL423712,
SPBio_001595,
SPBio_002412,
BPBio1_000541,
CHEMBL153479,
SCHEMBL7855003,
CHEMBL1477775,
DTXSID8022583,
BCBcMAP01_000092,
CHEBI:92994,
CTK1B6251,
KBio1_000027,
KBio2_001826,
KBio2_004394,
KBio2_006962,
KBio3_002050,
4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol,
CHEBI:135590,
JBDGDEWWOUBZPM-XYPYZODXSA-N,
NINDS_000027,
HMS2089D06,
HMS2231B19,
HMS3373J22,
ZINC587613,
ALBB-022461,
BCP04489,
HY-B1039,
BBL009896,
BDBM50395322,
MFCD02093079,
MFCD28143339,
STK711075,
AKOS005530704,
AKOS015889660,
AKOS027338704,
ZINC100001905,
ZINC100070274,
AC-8362,
ACN-026570,
AN-8090,
BCP9000283,
CCG-207907,
CS-4558,
DB06742,
MCULE-9463281275,
SB17463,
VA10248,
IDI1_000027,
SMP1_000014,
NCGC00016781-01,
NCGC00016781-02,
NCGC00016781-08,
NCGC00159399-02,
NCGC00371077-02,
AJ-23628,
LS-57030,
SMR000718792,
BCP0726000066,
SBI-0051766.P002,
AB0035941,
AB00514663,
FT-0622261,
FT-0630430,
FT-0661549,
R5537,
ST51014904,
Y0395,
D07442,
4-(2-amino-3,5-dibromobenzylamino)cyclohexanol,
AB00053639_13,
AB01275465-01,
683A915,
I01-2656,
SR-05000001463-1,
BRD-K11223672-003-03-7,
BRD-K11223672-003-04-5,
BRD-K56558538-003-02-8,
4-[(2-amino-3,5-dibromophenyl)methylamino-]cyclohexanol,
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexanol,
(1s,4s)-4-((2-amino-3,5-dibromobenzyl)amino)cyclohexanol,
4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol, trans-,
4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol,
4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexan-1-ol,
cis-4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol,
Cyclohexanol, 4-((2-amino-3,5-dibromobenzyl)amino)-, trans-,
trans-4-{[(2-amino-3,5-dibromophenyl)methyl]amino}cyclohexanol,
Cyclohexanol, 4-[[(2-amino-3,5-dibromo-phenyl)methyl]amino]-, trans,
Cyclohexanol, 4-(((2-amino-3,5-dibromophenyl)methyl)amino)-, trans- (9CI),
Ambroxol HCl,
Lasolvan,
ambroxils,
Ambroxocompren,
stasHustenloser,
Ambrohexal,
Ambrolitic,
Bronchopront,
Bronchowern,
Dinobroxol,
Farmabroxol,
Mucosolvan,
Mucotablin,
Sekretovit,
Abrohexal,
Ambrobeta,
Ambrofur,
Ambrolos,
Ambroten,
Ambroxin,
Duramucal,
Expeflen,
Flavamed,
Frenopect,
Padiamuc,
Surbronc,
Ebromin,
Gelopol,
Motosol,
Ambril,
Broxol,
Mibrox,
AmbroPuren,
Expit,
MucoFips,
stas Hustenloser,
stas-Hustenloser,
Ambro Puren,
Ambro-Puren,
Pect Hustenloser,
Ambroxol hydrochloride,
Pulmonal S,
Bisolvon AM,
Muco Fips,
Muco-Fips,
AM, Bisolvon,
Hustenloser, Pect,
Contac HustenTrunk,
Ambroxol [INN],
Larylin HustenLoser,
Therapin Hustenloser,
Contac Husten Trunk,
Contac Husten-Trunk,
Ringelheimer Pulmonal,
AMBROPP,
Larylin Husten Loser,
Larylin Husten-Loser,
Hustenloser, Therapin,
Pulmonal, Ringelheimer,
D03DSR,
Metabolite VIII, Bromhexine,
CID2132,
NA872,
C13-H18-Br2-N2-O,
AR-1F9025,
NA 872,
CS-O-00820,
CS-O-07155,
D000551,
2-Amino-3,5-dibromo-N-(trans-4-hydroxycyclohexyl)benzylamine,
Cis-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol Hydrochloride,
23828-92-4,
Cyclohexanol, 4-[(2-amino-3,5-dibromobenzyl)amino]-, trans-,
trans-4-[[(2-amino-3,5-dibromophenyl)methyl]amino]cyclohexanol,
Ciclohexanol, 4-[[(2-amino-3,5-dibromofenil) metil] amino]-, trans-,
19071-54-6,
|
| Complexity | 259 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 377.977g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 18 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 378.108g/mol |
| Monoisotopic Mass | 375.979g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 58.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 2.6 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H332-H335 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338-P310 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

